07971459383

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

ABIRAGIS-500 Tablet

Name: ABIRAGIS-500 Tablet
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 5000 INR
Availability: InStock

Price 5000 INR/ Pack

Get a Price/Quote

MOQ : 1 Pack

ABIRAGIS-500 Tablet Specification

Indication
Prostate cancer treatment

Dosage Form
Tablet

Salt Composition
Abiraterone Acetate 500 mg

Feature
High Purity, Anti-cancer, Prescription Only

Ingredients
Abiraterone Acetate, Excipients

Application
Oral administration for oncology patients

Physical Color/Texture
White to off-white, film-coated tablets

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
2 years

Administration Route
Oral

Packaging
Pack of 60 tablets

Warning
Not to be used in women or children, contraindicated in patients with hypersensitivity

Market Authorization Holder
Onkos Pharma India Pvt. Ltd.

Regulatory Approval
Approved by Indian Regulatory Authorities

Prescription Status
Prescription Required

Batch Number
As per manufacturer batch label

Side Effects
Fatigue, joint swelling, hypokalemia, hypertension

ATC Code
L02BX03

ABIRAGIS-500 Tablet Trade Information

Minimum Order Quantity
1 Pack

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Packs Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About ABIRAGIS-500 Tablet

Purchase the preeminent ABIRAGIS-500 Tablet, a best-seller in oncology care, expertly crafted by Onkos Pharma India Pvt. Ltd. This imposing, gilt-edged anti-cancer medication contains Abiraterone Acetate 500 mg, presented in high purity, white to off-white film-coated tablets. Each pack contains 60 tablets for oral administration, specifically tailored for prostate cancer treatment. Regulatory approval and premium manufacturing denote its safety and effectiveness. Please personalise your treatment under medical supervision as this prescription-only drug is not suitable for women, children, or patients with hypersensitivity. Store below 30C to maintain its gilt-edged efficacy.

Advanced Application & Personalised Oncology Care

ABIRAGIS-500 Tablet stands out as a prescription-only solution for prostate cancer treatment, designed exclusively for oral administration in adult oncology patients. The unique formulation ensures high purity and reliable therapeutic impact. Its white to off-white, film-coated tablets offer imposing support in managing disease, reflecting premium pharmaceutical standards. Patients benefit from differentiated safety measures and tailored usage, guaranteeing a personalised care approach in every dose prescribed by a medical professional.

Premium Export Logistics & Exceptional Market Reach

ABIRAGIS-500 Tablet is offered with efficient logistics from leading Indian ports, ensuring prompt and safe global delivery. Serving a gilt-edged clientele across major export markets, each shipment is handled with premium care. Onkos Pharma provides sample availability for rigorous evaluation, supporting a constructive proposal amount discussion. Partner with a preeminent exporter, supplier, and trader in India for dependable access to this leading oncology product, trusted by prescribing professionals worldwide.

FAQ's of ABIRAGIS-500 Tablet:

Q: How should ABIRAGIS-500 Tablet be administered for optimal results?

A: ABIRAGIS-500 Tablet is intended for oral administration. Always follow your healthcare provider's instructions regarding dosage and schedule to achieve the best therapeutic outcomes.

Q: What are the main benefits of using ABIRAGIS-500 Tablet in prostate cancer treatment?

A: This product offers high purity Abiraterone Acetate, recognised for its efficacy and safety in prostate cancer management, making it a preeminent choice among oncologists.

Q: When should this medication not be used?

A: ABIRAGIS-500 Tablet must not be used in women, children, or individuals with known hypersensitivity to its components as indicated in the warning and contraindications section.

Q: Where is ABIRAGIS-500 Tablet approved and manufactured?

A: It is approved by Indian Regulatory Authorities and manufactured by Onkos Pharma India Pvt. Ltd., ensuring compliance with stringent quality standards.

Q: What are the possible side effects associated with ABIRAGIS-500 Tablet?

A: Some patients may experience fatigue, joint swelling, hypokalemia, or hypertension. Always report unusual symptoms to your healthcare provider for prompt assessment.